Patient Centricity — taking care of our most valuable asset!
April 2,2018 asikora

“Patient centricity” is the process of designing a service or solution around the patient; more specifically, it is collectively defined as “Putting the patient first in an open and sustained engagement of the patient to respectfully and compassionately achieve the best experience and outcome for that person and their family.

It is important that patient-centric approaches be applied in all research activities, including bioanalysis.
Every day, research organizations, such as Altasciences Clinical Research, explore and implement bioanalytical solutions and innovative tools to improve the comfort of clinical trial participants. As an example, the volumetric absorptive microsampling (VAMS) technique was developed to eliminate invasive and large blood draws for patients by allowing the collection of blood via a finger prick; which is ideal for pediatric studies. With this technique, study participants can be trained to collect blood samples from the comfort of their own home, in just a few easy steps, and then ship the samples to a laboratory for analysis.

Patient-centric approaches have multiple benefits, not only for the patient, but also for the sponsor. With VAMS, for example, patients benefit from an easy-to-use technique requiring low blood volume samples that can be drawn from home and stored at room temperature. For the sponsor, VAMS provides an additional solution for higher patient engagement and compliance

It is crucial that providers investigate all available tools and approaches to maximize patient engagement. Altasciences’ extensive expertise with techniques such as VAMS, as well as with generic compounds and New Molecular Entities (NME) in all biological matrices, contributes to methods that are highly sensitive and reliable. By combining highly sensitive platforms and multiple advanced techniques, we are able to provide patient-centric bioanalytical support for all stages of drug development, for both small and large molecule programs.

Or meet with us at the 12th WRIB, April 9-13, in downtown Philadelphia — Booth #54.
You may also request our scientific poster about VAMS being presented at the conference.

Leave a Reply

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Subscribe to our Blog

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

About Our Blog

Welcome to VA Confidential, the official blog of Vince & Associates Clinical Research. Don't know us? In a few words, we are a premier clinical research site combining the power of physician-led study teams and the luxury atmosphere of our state-of-the-art, multi million-dollar clinical pharmacology unit.

We're lucky to have a staff of smart, passionate people doing incredible things in areas like Phase I-II Proof-of-Concept, adaptive clinical trial design, First-in-Human, Single and Multiple Ascending Dose, and a host of other early phase clinical trials. We use this blog to share some of the cool things going on around here, share knowledge and innovation in clinical pharmacology and promote health and wellness.

Of course what makes this blog really exciting is YOU — so join the conversation!